Lecture 21 - Fibrosing Disease of the Lung Flashcards

1
Q

What is fibrosis?

When does it occur?

A

Fibrosis: abnormal deposition of ECM

Occurs in:
• Chronic obstructive diseases (Asthma, COPD: emphysema, bronchitis)
• Fibrosing disease of the lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the most common fibrosing disease of the lung?

What are some other aetiologies?

A
  1. IPF: Idiopathic pulmonary fibrosis
    • most common

Known causes:

2. Iatrogenic
 • antibiotics
 • anti-inflammatories
 • radiotherapy
 • chemotherapy
  1. Inhaled dust particles
    • Silicates
    • Asbestos

etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
Describe IPF:
 • Major features
 • Median age of diagnosis
 • Location of pathology
 • Risk factors
 • Epidemiology
 • Prognosis
 • Symptoms
A
  • Chronic & irreversible
  • Usually lethal
  • Unknown cause

Median age of diagnosis:
• 66 years

• Limited to the lungs

Risk factors:
• Cigarette smoking
• Wood & metal dust exposure
• Genetic transmission

Epidemiology:
• Men (predominantly)
• Rising incidence

Prognosis:
• about 3 year survival after diagnosis

Symptoms:
• Cough
• Progressive dyspnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the progression of IPF

What are the different clinical phenotypes?

A

Progression:

  1. Asymptomatic period
    • Lasts years
    • Progressive degeneration of lung function
  2. Onset of symptoms
    3a. Rapid progressive course

3b. Slow progressive course
+ acute exacerbations which speed up the progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is IPF diagnosed?

What are the major and minor criteria

A
  1. High resolution computed tomography
    • Heterogeneous gaps in tissue
    • Thickened septa between lobes (interstitial tissue)
  2. Surgical biopsy & high power histology

Fibroblastic loci:
• Observed as pale foci
• Full of fibroblasts

Histopathologic hallmark:
Heterogenous appearance:
 • Areas of fibrosis
 • Scarring
 • Honeycomb change
alternating with regions that are less affected.

Major criteria:

  1. Exclusion of other known causes if interstitial lung disease
  2. Abnormal lung function tests
  3. Abnormalities in chest radiographs
Minor criteria:
 • > 50 years
 • Insidious onset
 • Duration of more than 3 months
 • Crackles: breathing causes a crackling sound
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the histological and radiological pattern of IPF?

A

Usual interstitial pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the gross appearance

A

Cobblestone:
• enlarged airspaces

Gross honeycombing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the microscopic appearance

A

“Usual interstitial pneumonia”
• Patchy fibrotic reaction
• Spatial heterogeneity

Fibrotic foci
• Epithelial cells still present, but they have become cuboidal

  • Paucity of inflammation
  • Lack of uniform involvement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe acute exacerbations in IPF
What are the pathological features?
What does it lead to in terms of clinical presentation?

A

Leads to rapid decline in lung function

Diffuse alveolar damage

Pathological features:
 • Type II pneumocyte hyperplasia
 • Oedematous alveolar septa
 • Hyaline membranes
 • Squamous cell metaplasia (in alveoli)
 • Thrmobi in pulmonary arteries
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How may IPF be studied?

A
  1. Biopsies from patients
    • Dead tissue
    • Only can do observational studies or immunohistochemistry
  2. Cell line studies
    • However, the cell lines are not typical and representative of the disease
    • Different micro-environment
  3. Primary cell culture
    • Cells taken directly from the person
    • Cells retain the phenotype
    • More useful and representative
  4. Animal models
    • Bleomycin in mice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What was Bleomycin originally?

A

A cancer drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the Bleomycin model of IPF

Pros / cons

A

Bleomycin causes pulmonary fibrosis in the lung similar to IPF

The drug administered to mice
Mice get IPF

Drawbacks:
• Mouse lifespan & anatomy are different
• Lacks human chronicity
• Bleomycin releases free radicals and causes DNA damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the paradigm of IPF?

A

Formerly: Chronic inflammation

Now: Aberrant wound healing (disease starting at epithelial level)

  1. Injury of alveolar epithelial cells

– TGF-B induction –

  1. Activation of fibroblasts and myofibroblasts

– ECM deposition –

  1. Pulmonary fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the genetic component of IPF?

A

Specific genes expressed in alveolar epithelial cells involved:

  • MUC5B: codes for mucin
  • TERT/TERC: telomere length
  • SPA & SPC: surfactant protein

Changes in these genes are observed in disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the observation of ER stress

A

Alveolar epithelial cells observed to have ER stress

Unfolded protein response:

  1. Environmental insults or genetic predisposition (MUC5B etc.) → unfolded proteins
  2. Stress detected in cell
  3. Apoptosis and / or fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are some environmental insults that lead to the UPR?

A

Viral infection

Smoking

17
Q

What is TGF-β?

How does it become activated?

What is the major source of it?

What processes does it bring about?

A

Key fibrotic cytokine

Inactive form:
• LAP (latency associated peptide) bound

During fibrosis, an integrin binds to the LAP and the TGF-β is released and becomes activated

Source:
• Epithelial cells

Function:
 • Increased collagen synthesis
 • Differentiation & stimulation of fibroblasts into myofibroblasts
 • Epithelial cell proliferation
 • EMT
18
Q

What is EMT?

What is the role in IPF?

A

Epithelial-mesenchymal transition

Transition:
Epithelial cell → fibroblast

Controversy:
• only demonstrated in vitro
→ not representative of the body

19
Q

List the profibrotic attributes of epithelial cells in IPF

A
• ER stress
 • Genetic mutations:
- SPC & SPA
- MUC5B
- TERT
 • TGF-β
20
Q

Describe the role of external stressors in IPF

Give a specific example

A

Not solely genetic component, but also external insults

KO mice for the particular genes do not spontaneously develop pulmonary fibrosis, but can develop it with external stimuli

Examples:
 • Gastrointestinal reflux
- proteolytic enzymes, acid & food enter lungs
- damage to epithelial cells
 • Treatment: proton pump inhibitors
21
Q

What is the role of the mesenchyme in IPF?

A

Important role of mesenchyme & fibroblasts

Fibrocytes:
• secrete collagen

Increased presence of fibrocytes in circulation associated with poor prognosis and exacerbation

22
Q

What are myofibroblasts?

How are they produced?

A

Derived from common progenitor fibrocytes (from bone marrow)

Three paths of differentiation:
1. EMT: Epithelial cell → fibroblast → myofibroblast

  1. Fibrocyte in blood → fibroblast → myofibroblast
  2. Resident fibroblast → myofibroblast

TGF-β:
• Fibroblasts differentiate into myofibroblasts under TGF-β signalling
• Need constant signalling, otherwise they go away

23
Q

What are fibrocytes?

A

From the bone marrow

Present in the blood

Recruited to sites of injury

Precursor for fibroblasts and myofibroblasts

24
Q

How are fibrocytes recruited by the alveolar epithelium?

A

Fibrocyte: CXCR4

Alveolar epithelium: CXCL12

25
What is special about the fibroblasts in IPF?
* Resistant to apoptosis (pro-survival genes FoxO3a) * Remain in the lung for a long time * Hyper-proliferative
26
Describe the similarity of IPF to cancer
* Pro-survival genes * Invasive * Down regulation of apoptosis * Foci of fibroblasts are like little tumours
27
Describe epithelial-mesenchymal cross-talk
Communication between epithelial cell and fibroblast • Normally in close contact • Epithelial cell releases products that stimulate fibroblasts: - TGF-β - GFs * Mesenchyme interacts with ECM * Aberrant ECM drives changes in fibroblast as well as epithelial cells
28
What is the role of inflammation in IPF?
Macrophages: • make most of the active TGF-β • responsible for activating latent TGF-beta • predominantly M2 macrophages
29
What are the two types of macrophages?
1. M1: Inflammatory • collagen turn over 2. M2: Profibrotic • produces TGF-β • collagen production etc.
30
Describe propagation of lung fibrosis
1. Predisposition • Genetic factors • External stressors • Ageing 2. Initiation • TGF-β activation • UPR activation • Fibrocyte recruitment 3. Progression • Fibroblast differentiation • ECM remodelling • Epigenetic change * Still don't know why IPF is so relentless, is controversial * External stressors may be important in propagation * ECM contains molecules that signal mesenchymal cells to secrete more ECM (vicious cycle) * "Feed forward auto amplified loop of matrix remodelling" * There may be a role of epigenetics
31
What are some therapeutic strategies for IPF?
1. Combination therapy of antioxidants & anti-inflammatories: • Prednisolone etc. • Slower decline in lung function 2. Antifibrotic agents • IFN-gamma 3. Endothelin receptor antagonists 4. Lung transplant • only proven treatment
32
What are the therapeutic challenges in IPF?
There is much redundancy in the pathways leading to the fibrosis Simply knocking out one is not sufficient Each pathway needs to be targeted